The UK Government's current proposal to fortify one type of flour with folic acid is inadequate as it suggests a low dose that would fail to prevent hundreds of cases of severe birth defects each year ...

Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving ...

This is a review of the proceedings of the Second International Conference on Neural Tube Defects. This was an interdisciplinary meeting with the common emphasis on neural tube defects research. The ...

In a study published in the New England Journal of Medicine, women taking an HIV therapeutic drug containing dolutegravir have a higher risk of giving birth to children with neural tube defects ...

We read with interest the recent article that found the recurrence risk of any type of neural tube defect (NTD) among siblings of individuals with lipomyelomeningocele to be consistent with that for ...

Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving ...

(HealthDay)—The prevalence of neural tube defects (NTDs) is 7.0 per 10,000 live births in HIV-exposed pregnancies, which is similar to the prevalence in the general population, according to research ...

Neural tube defects happen because the neural tube does not fuse during early embryonic development. Open neural tube defects are those in which the affected region of the neural tube is exposed on ...

About 300,000 to 400,000 fetuses per year from mothers with diabetes develop neural tube defects -- when the tissue that eventually forms the brain and spinal cord fails to form properly -- which can ...

Please provide your email address to receive an email when new articles are posted on . New data from the ongoing Tsepamo study in Botswana showed that the prevalence of neural tube defects, or NTDs, ...

Dolutegravir is a preferred medication for treating HIV infection, but it recently has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving ...